Marks Group Wealth Management Inc raised its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 3.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,996 shares of the technology company's stock after purchasing an additional 3,164 shares during the quarter. Marks Group Wealth Management Inc owned 0.08% of Amdocs worth $8,601,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC acquired a new position in shares of Amdocs in the first quarter worth $27,000. AdvisorNet Financial Inc increased its stake in shares of Amdocs by 382.9% in the first quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock worth $31,000 after acquiring an additional 268 shares during the last quarter. NBC Securities Inc. acquired a new position in shares of Amdocs in the first quarter worth $31,000. Jones Financial Companies Lllp acquired a new position in shares of Amdocs in the fourth quarter worth $36,000. Finally, Tower Research Capital LLC TRC increased its stake in shares of Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after acquiring an additional 208 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
Amdocs Stock Up 1.3%
NASDAQ:DOX traded up $1.12 during trading hours on Wednesday, reaching $89.17. The company's stock had a trading volume of 630,764 shares, compared to its average volume of 666,282. The company has a market cap of $10.07 billion, a price-to-earnings ratio of 18.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.52. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The business's 50-day moving average is $91.56 and its 200-day moving average is $88.37. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.07. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The firm had revenue of $1.13 billion during the quarter, compared to analysts' expectations of $1.12 billion. During the same period in the prior year, the company posted $1.56 earnings per share. Amdocs's revenue for the quarter was down 9.4% on a year-over-year basis. Equities research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date is Monday, June 30th. Amdocs's dividend payout ratio (DPR) is 44.42%.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the stock. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday, June 7th. Wolfe Research started coverage on shares of Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating on the stock. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Amdocs has an average rating of "Buy" and a consensus target price of $105.33.
View Our Latest Analysis on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.